Related Experiment Video
Updated: Feb 17, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
DIDS inhibits overexpression BAK1-induced mitochondrial apoptosis through GSK3β/β-catenin signaling pathway
Xiayun Yang1, Shusheng Tang1, Daowen Li1
1Department of Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, Haidian District, China.
Abstract:
Bcl-2 homologous antagonist/killer (BAK1) is a critical regulator of mitochondrial apoptosis. Although upregulation of BAK1 induces apoptosis has been established, the underlying molecular mechanism is far from clear. 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS), an organic anion used as a blocker of anion exchangers and chloride channels, has been proved to rescue cell apoptosis both in vitro and in vivo. However, whether DIDS can inhibit BAK1-induced mitochondrial apoptosis remains undefined. Thus, this study aimed to explore whether DIDS could protect BAK1-induced apoptosis through GSK3β/β-catenin signaling pathway. The results showed overexpression BAK1 in 293T cells induced mitochondrial apoptosis accompanied by increasing the expression levels of cleaved caspase-9, -3, poly (ADP-ribose) polymerase (PARP) and reducing the MMP. Furthermore, overexpression BAK1 decreased the expression levels of Ser9-GSK3β and β-catenin. In addition, lithium chloride (LiCl), an activator of Wnt/β-catenin signaling pathway, markedly attenuated overexpression BAK1-induced mitochondrial apoptosis by restoring the expression levels of Ser9-GSK3β and β-catenin. Finally, DIDS absolutely abolished overexpression BAK1-mediated mitochondrial apoptosis through recovering the expression levels of Ser9-GSK3β and β-catenin. Taken together, our results reveal that DIDS blocks overexpression BAK1-induced mitochondrial apoptosis through GSK3β/β-catenin pathway.
Insights
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) prevents cell death induced by Bcl-2 homologous antagonist/killer (BAK1) overexpression. DIDS protects against BAK1-induced apoptosis by modulating the GSK3β/β-catenin signaling pathway.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Bcl-2 homologous antagonist/killer (BAK1) is a key regulator of mitochondrial apoptosis.
- The precise molecular mechanisms underlying BAK1-induced apoptosis are not fully understood.
- 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) is known to protect cells from apoptosis.
Purpose of the Study:
- To investigate whether DIDS can inhibit BAK1-induced mitochondrial apoptosis.
- To explore the role of the GSK3β/β-catenin signaling pathway in DIDS's protective effect.
Main Methods:
- Overexpression of BAK1 in 293T cells.
- Analysis of apoptosis markers (cleaved caspase-9, -3, PARP) and mitochondrial membrane potential (MMP).
- Assessment of GSK3β and β-catenin expression levels.
- Treatment with DIDS and lithium chloride (LiCl).
Main Results:
- BAK1 overexpression induced mitochondrial apoptosis, increasing cleaved caspase-9, -3, PARP, and decreasing MMP.
- BAK1 overexpression reduced Ser9-GSK3β and β-catenin levels.
- LiCl attenuated BAK1-induced apoptosis by restoring Ser9-GSK3β and β-catenin.
- DIDS completely blocked BAK1-induced apoptosis by restoring Ser9-GSK3β and β-catenin.
Conclusions:
- DIDS inhibits BAK1-induced mitochondrial apoptosis.
- The protective mechanism of DIDS involves the GSK3β/β-catenin signaling pathway.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
The Intrinsic Apoptotic Pathway
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

